NCT04924699 2023-03-17A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast CancerShanghai Miracogen Inc.Phase 2/3 Unknown350 enrolled
NCT02568839 2020-08-13PREDIX HER2Karolinska University HospitalPhase 2/3 Active not recruiting202 enrolled